|

BL-B16D1 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1: 3

Top Sponsors

  • Sichuan Baili Pharmaceutical Co., Ltd.3

Indications

  • Solid Tumor3
  • Cancer3
  • Head and Neck Squamous Cell Carcinomas1
  • Breast Cancer1

Other3 trials

A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1
A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Phase 1
A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.